Nearly a year and a half year after Hyderabad-based pharma major Aurobindo Pharma announced its big ticket, $900 million deal to acquire Sandoz Inc’s US generic oral solids and dermatology businesses, the company on Thursday informed the bourses that the deal has been mutually called off due to delays in getting approvals from the US […]